Transcription of [Product Monograph Template - Schedule D]
{{id}} {{{paragraph}}}
OZEMPIC (semaglutide injection) product Monograph Page 1 of 56 product Monograph INCLUDING PATIENT MEDICATION INFORMATION OZEMPIC semaglutide injection 2 mg/pen ( mg/mL) Pre-filled pen delivering doses of mg or mg and Pre-filled pen delivering doses of 1 mg ATC code: A10BJ Antihyperglycemic Agent Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Novo Nordisk Canada Inc. 101-2476 Argentia Road Mississauga, Ontario L5N 6M1 Submission Control No: 202059 Date of Approval: January 4, 2018 OZEMPIC (semaglutide injection) product Monograph Page 2 of 56 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION.
OZEMPIC® (semaglutide injection) Product Monograph Page 1 of 59 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . OZEMPIC ® semaglutide injection . 2 mg/pen (1.34 mg/mL) Pre-filled pen delivering doses of 0.25 mg or 0.5 mg
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}